WRBY

Warby Parker Inc. · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 12:40 UTC

Last close

21.29USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-26

2548.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-26
The filing itself
-0.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
0.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
5.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
The filing itself
0.63Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-08-06
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.11 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.45x

-0.03x

-7.10x

1.16x

1.03x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales1.45x
Its own average over 7 years, 602.3M.
Profit-0.03x
Its own average over 7 years, -56.1M.
Free cash flow-7.10x
Its own average over 7 years, -6.2M.
Debt1.16x
Its own average over 4 years, 201.6M.
Price1.03x
Its own average over 6 years, 21. Market data, 2026-11-04

Free cash flow is furthest from its own average, at -7.10 times.

Sales is 1.45 times its own 7-year average; Profit is -0.03 times its own 7-year average; Free cash flow is -7.10 times its own 7-year average; Debt is 1.16 times its own 4-year average; Price is 1.03 times its own 6-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-26

Sales against its own 7-year average1.45
Source
filed
Statement
income
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
The filing itself
Profit against its own 7-year average-0.03
Source
filed
Statement
income
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
The filing itself
Free cash flow against its own 7-year average-7.10
Source
filed
Statement
income
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
The filing itself
Debt against its own 4-year average1.16
Source
filed
Statement
income
Fiscal year
2025
Accession
0001504776-26-000006
Reported in
USD
The filing itself
Price against its own 6-year average1.03Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD